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Background. The mimetic compound OTR4120 may replace endogenous-degraded heparan sulfates that normally maintain
the bioactivity of growth factors that are important for tissue repair. Herein, we investigated the eﬀect of OTR4120 on
the healing of normal colonic anastomoses. Methods. We evaluated the following two treatment groups of male Sprague
Dawley rats (220–256 g): control-treated colonic anastomoses (n = 25) and OTR4120-treated colonic anastomoses (n = 25).
We resected 10mm of the left colon and then applied either saline alone (control) or OTR4120 (100 μg/mL) in saline to
the colonic ends before an end-to-end single-layer anastomosis was constructed and again on the anastomosis before the
abdomen and skin were closed. Results. On postoperative day 3, the anastomotic breaking strengths were 1.47 ± 0.32N
(mean ± SD) in the control group and 1.52 ± 0.27N in the OTR4120-treated animals (P = 0 622). We also found that the
hydroxyproline concentration (indicator of collagen) in the anastomotic wounds did not diﬀer (P = 0 571) between the
two groups. Conclusions. Our data demonstrate that a single local application of OTR4120 intraoperatively did not
increase the biomechanical strength of colonic anastomoses at the critical postoperative day 3 when the anastomoses are
the weakest.
1. Introduction
Anastomotic leakage (AL) remains one of the most devas-
tating complications after colorectal surgery despite
improvements in surgical techniques and perioperative
management. The incidence of AL is 3–7% after colocolo-
nic anastomoses and 10–20% after colorectal anastomoses
[1–3]. AL is associated with increased risks of morbidity,
short-term mortality, permanent fecal diversion, cancer
recurrence, and poor overall long-term survival [1, 4–7].
Many pharmaceuticals have been investigated but none have
reached clinical usage for AL prophylaxis [8, 9].
Extracellular matrix (ECM) components play key roles in
wound healing [10]. Previous experimental studies of
uncomplicated anastomoses have demonstrated that there
is substantial degradation of the submucosal ECM, which
leads to lowered breaking strength, of experimental anasto-
moses three days postoperatively [11–16]. Thereafter, the
anastomotic strength increases due to increased collagen bio-
synthesis [11–13].
Proteoglycans are a subset of complex ECM proteins with
attached glycosaminoglycans and have unique properties.
Heparan sulfates are glycosaminoglycans that protect
heparin-binding growth factors, such as ﬁbroblast growth
factor-2 and transforming growth factor-β from proteolysis.
Heparin-binding growth factors stimulate cell migration,
proliferation, and diﬀerentiation [17–19]. Regenerating
agents (RGTAs), including OTR4120 (OTR3, Paris, France),
are synthetic heparan sulfate analogs derived from dextran
[20]. These agents mimic the protective properties of
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endogenous heparan sulfates and enhance the in vivo bio-
availability of heparin-binding growth factors [17, 18, 21].
These compounds may also directly prevent growth factor
proteolysis by inhibiting serine proteinases such as neurophil
elastase, plasmin, and cathepsin G [22–24]. RGTAs improve
regeneration or healing after bone, muscle, tendon, skin,
cornea, and colon insults [17, 18, 21, 25, 26].
Meddahi et al. [17] studied the eﬀect of a RGTA in an
animal model of anastomotic wound repair in the left colon.
Their data showed that RGTA11 caused increased anasto-
motic bursting pressure 2 days after construction of the anas-
tomoses but not after 4 or 7 days. Breaking strength is
another biomechanical parameter for anastomosis integrity.
Furthermore, the authors did not present biochemical
metrics for wound healing [17].
The aim of this study was to investigate the impact of
OTR4120 on the early healing of experimental colonic
anastomoses under normal conditions by measuring the
breaking strength and hydroxyproline (indicator for colla-
gen). Because RGTAs have shown beneﬁcial eﬀects on skin
wound healing [25, 26], we also investigated the eﬀect of
OTR4120 on the breaking strength of incisional skin wounds
in the laparotomized animals.
2. Materials and Methods
The study was performed at the Panum Institute, University
of Copenhagen, Copenhagen, Denmark. The study protocol
was approved by the Animal Experiments Inspectorate of
The Danish Ministry of Justice (2014-15-0201-00329).
The ARRIVE guidelines were followed [27]. The experi-
mental work was performed over a 3-week period. The
investigators were blinded throughout the study and during
data interpretation.
2.1. Animals. In this study, 50 male Sprague Dawley rats
(Taconic Biosciences A/S, Lille Skensved, Denmark) weigh-
ing 220–256 g were used. The animals were housed in stan-
dard type III cages with a 12-hour light cycle and had free
access to tap water and standard pellets. Two animals per
cage were acclimatized for at least 10 days before surgery.
The rats were then transferred to individual cages and
weighed on the day of surgery (day 0) and then again on days
1, 2, and 3. Their food consumption was also recorded on
days 1, 2, and 3.
2.2. Sample-Size Calculation and Randomization. The sample
size was calculated using data from one of our prior studies
[15]. Three days postoperatively, the mean± standard deriva-
tion (SD) anastomotic breaking strength was 1.19± 0.34N in
the control group and 1.54± 0.40N in the experimental
group. Based on a signiﬁcance level (α) of 5% and a power
(1-β) of 90%, we needed 24 animals in each group to detect
an increase in anastomotic breaking strength from 1.19N
to 1.54N (average SD: 0.37N). We decided to include 25 ani-
mals in each group to account for 6% mortality.
The rats were randomized in blocks of 8 to control or
OTR4120 treatment groups using a computer-generated
sequence obtained from http://random.org.
2.3. Anesthesia and Analgesics. Anesthesia was introduced
with isoﬂurane (Piramal Healthcare, Morpeth Northum-
berland, UK) 3.5%/O2 (1.5 L/min) and maintained with
2.0%/O2. Bupivacain (Marcaine®; AstraZeneca, Copenha-
gen, Denmark) 2mg/kg was administered subcutaneously
(s.c.) at the incisional site. The preoperative and postoper-
ative analgesia was provided by per os 0.4mg/kg bupre-
norphine (Temgesic®; Rickitt Benckiser, Berkshire, UK)
mixed in hazelnut butter at 12-hour intervals.
2.4. Aseptic Surgical Procedures and OTR4120/Control
(Saline) Administration. The abdomen was shaved, disin-
fected with 0.5% chlorhexidine gluconate in ethanol/isopro-
panol (Meda, Allerød, Denmark) and then covered with
sterile surgical adhesive drape (Barrier®; Mölnlycke Health
Care, Göteborg, Sweden). The peritoneal cavity was exposed
through a 40mm midline incision. A 10mm segment of
the left colon was resected with approximately 60mm
from the anus, and the fecal contents were removed. We
applied 80μL of control (0.9% NaCl) or 80μL OTR4120
(100μg/mL) in saline corresponding to 8μg OTR4120 to
each colonic end using a sterile low-density polyethylene
Pasteur pipette (VWR, Radnor, PA, USA) based on the
randomized allocation. An end-to-end single-layer anasto-
mosis was constructed using 8 interrupted polypropylene
monoﬁlament 6/0 sutures (Premilene®; B. Braun Surgical,
Jaén, Spain) as shown in Figure 1. We then applied 80μL of
control or 80μL OTR4120 corresponding to 8μg OTR4120
to the sutured anastomosis. The total volume of control
or OTR4120 solution applied per anastomosis was 240μL
corresponding to 0 or 24μg OTR4120.
Figure 1: Colon anastomosis on day 0.
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The abdominal muscles and the transverse fascia
were closed using 8 interrupted polypropylene 4/0 sutures
(Premilene). Before closing the skin, we applied 120μL of
control or 120μL OTR4120 (100μg/mL) to each skin wound
edge about 30 minutes after the laparotomy was performed
[25, 26]. The skin was closed by 8 titanium clips (Appose
ULC; Covidien, Mansﬁeld, MA, USA). Then, an additional
240μL of control or 240μL OTR4120 were applied to the
incisional skin wound. The total volume of control or
OTR4120 solution applied per skin wound was 480μL corre-
sponding to 0 or 48μg OTR4120.
After surgery, the rats were given 5mL saline s.c. for
rehydration.
2.5. Evaluation of Intraperitoneal Adhesions, Tissue Sampling,
and Breaking Strength Determinations. On postoperative day
3, the rats were anesthetized and the skin clips were removed.
The skin was resected en bloc (30mm× 40mm). The skin
bloc was divided into two 15mm (width)× 40mm (length)
strips with scissors. The strips contained the incision in the
middle and were immersed in saline. The abdominal cavity
was reopened and the degree of adhesion formation was
assessed using the following scale: 0 = no adhesions; 1 = min-
imal adhesions, mainly between the anastomosis and the
omentum; 2 = moderate adhesions occurring between the
omentum and the anastomotic site and between the anasto-
mosis and a loop of small bowel; and 3 = severe and extensive
adhesions, including abscess formation [28]. The anasto-
mosis was then freed of adhesions. A 40mm-long colonic
segment with the anastomosis in the middle was resected,
and the fecal contents were gently evacuated. The anasto-
mosis was examined macroscopically for signs of AL [29]
and immersed in saline. The rats were then sacriﬁced by
cervical dislocation.
The skin strips and anastomoses with sutures in situ were
mounted in a materials testing machine (LF Plus; Lloyd
Instruments, Bognor Regis, UK) with a 10mm gap between
the clamps. The tissues were stretched in the vertical direc-
tion at a constant speed of 10mm/minute until rupture
[14]. The testing was performed within 10 minutes of tissue
excision. The breaking strengths in Newtons (N) were
determined from the load-deformation curve (Nexygen
software; Lloyd Instruments). The site of rupture was
noted (anastomotic/incisional line or outside the anasto-
motic/incisional line). The mean breaking strength of the
two skin strips from each animal was used in the subsequent
data processing.
One tissue sample from each anastomotic wound was
excised and placed in a cryogenic tube (Greiner Bio-One
GmbH, Frickenhausen, Germany). The tissue was snap-
frozen in liquid nitrogen and then transferred to −80°C until
analysis for hydroxyproline as an indicator of collagen.
2.6. Hydroxyproline Determination. The tissue samples from
the anastomotic wound were dried to constant weight (9.6
± 2.6mg, n = 49) at 100°C and hydrolyzed in 6mol/L hydro-
chloric acid for 18 hours at 110°C. The samples were dried in
a heating block and washed and dried with distilled water 3
times. The samples were then dissolved in 1mL acetate-
citrate buﬀer. Chloramine-T was added to the samples, and
the solution was incubated at room temperature for 20
minutes. We then added p-dimethylaminobenzaldehyde-
perchloric acid, and the samples were incubated for 25
minutes in a 60°C water bath [30]. The optical density was
measured at 570nm and the hydroxyproline concentration
was derived from the standard linear curve for L-
hydroxyproline (0–10μg/mL). The results are expressed as
microgram (μg) hydroxyproline per mg dry tissue weight.
All measurements were performed in duplicate.
2.7. Statistical Analyses. All data were tested for normality
using Kolmogorov-Smirnov’s test and histograms. The
breaking strength of the colonic anastomoses and the inci-
sional skin wounds, colonic hydroxyproline concentration,
and body weight were compared with the two-sided unpaired
t-test. These data are presented as the mean± SD or mean
± SEM where indicated. The Mann-Whitney U test was used
to compare the adhesion score and food consumption
between the two groups. These results are presented as the
median (interquartile range). A value of P < 0 05 was con-
sidered statistically signiﬁcant. SPSS version 22.0 (IBM,
Chicago, IL, USA) was used for the statistical analyses.
3. Results
One rat in the OTR4120 group died during recovery from
anesthesia day 0.
3.1. Body Weights and Food Consumption. There was no
diﬀerence in mean body weight between the control and
OTR4120 groups on the day of surgery day 0 (Table 1).
The mean body weights were signiﬁcantly (P < 0 001)
reduced in both groups from day 0 to day 3. However,
the body weights did not diﬀer signiﬁcantly between the
two groups on day 1, 2, or 3. In addition, postoperative food
consumption did not diﬀer signiﬁcantly between the groups
on day 1, 2, or 3 (Table 2).
Table 1: Animal body weights (g) of the two groups.
Group
Day
0 1 2 3
Control 276± 27 265± 26 266± 27 268± 26
P 0.517 0.387 0.560 0.829
OTR4120 282± 29 272± 28 270± 28 269± 28
Values are the mean ± SD.
Table 2: Postoperative food consumption (g/day) in the two groups.
Group
Day
1 2 3
Control 5.5 (2.3–7.0) 8.3 (6.0–11.8) 10.8 (9.0–14.5)
P 0.413 0.059 0.316
OTR4120 3.3 (1.9–5.6) 5.0 (2.1–9.4) 10.3 (8.4–13.3)
Values are the median (interquartile range).
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3.2. Adhesion Formation. The majority of rats had formed
minimal intra-abdominal adhesions 3 days after surgery.
The adhesion scores did not diﬀer (P = 0 445) between the
control and OTR4120 groups (Figure 2).
3.3. Anastomotic Wound Healing. None of the rats showed
signs of AL. There were two colonic anastomoses from the
OTR4120 group that broke outside the anastomotic line
and were therefore excluded from the primary statistical
analysis. The breaking strength of the anastomoses in the
control group was 1.47± 0.32N (mean± SD, n = 25) and
1.52± 0.27N (n = 22) in the OTR4120 group (Figure 3). This
diﬀerence was not signiﬁcantly diﬀerent (P = 0 622). Fur-
thermore, an intention-to-treat analysis that included
data from all animals did not show a signiﬁcant diﬀerence
in anastomotic breaking strength either between the two
groups (P = 0 799).
The anastomotic wound hydroxyproline concentration
in the control group was not signiﬁcantly (P = 0 571) diﬀer-
ent from that of the OTR4120 group (Figure 4).
3.4. Breaking Strength of Incisional Skin Wounds. All the skin
strips broke in the midline incision. Two wounds in the con-
trol group and one wound in the OTR4120 group were
excluded due to technical failures. The breaking strength of
wounds in the control group was 0.64± 0.15N (mean± SD,
n = 23) and 0.67± 0.23N (n = 23) in the OTR4120-treated
skin wounds. These values were not signiﬁcantly diﬀerent
(P = 0 737).
4. Discussion
The mimetic compound OTR4120 is thought to replace
endogenous-degraded heparan sulfates that normally main-
tain the bioactivity of growth factors important for tissue
repair [17, 18, 21, 25, 26]. In this study, we demonstrated that
a single intraoperative topical application of OTR4120 did
not increase the biomechanical strength of colonic anasto-
moses on postoperative day 3 in male rats.
We used data from the study by Krarup et al. to calculate
the sample size [15]. The variability in anastomotic breaking
strength measurements expressed as the coeﬃcient of varia-
tion was 20% in the present study compared with 27% in
the study by Krarup et al. [15]. Furthermore, post hoc analy-
ses of our generated data revealed a 20% risk (type II error) of
overlooking increased breaking strength of 0.25N with
OTR4120 treatment of the colonic anastomoses with 95%
conﬁdence. Taken together, these calculations suggest that
the number of animals used in our study was suﬃcient
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Figure 2: Intra-abdominal adhesion formation on postoperative
day 3 in the control (open bars) and OTR4120 (black bars)
groups [28].
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Figure 3: Breaking strength of colonic anastomoses on
postoperative day 3 in the control (open bars) and OTR4120
(black bars) groups. Values are the mean± SEM.
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postoperative day 3 in the control (open bars) and OTR4120 (black
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to detect clinically signiﬁcant diﬀerences in anastomotic
breaking strength between the control and OTR4120 groups.
It should be emphasized that the biomechanical analyses
were performed on one time point only. We chose postoper-
ative day 3 because numerous studies have shown that the
anastomoses are the weakest [11–16] and therefore most
probable to dehisce on postoperative day 3.
Our ﬁndings contrast with those of a previous study on
RGTA11, which is an analog of OTR4120 [17]. In their study,
the colonic ends were immersed in the RGTA11 solution
(50μg/mL) for 2 minutes before the colonic anastomoses
were constructed in 10 male rats per group. Our dosing
protocol diﬀered from that of Meddahi et al. [17]. First,
we used twice the concentration of the OTR4120 solution
(100μg/mL). Secondly, apart from applying the compound
to the cut colonic ends before being sutured similar to
Meddahi et al. [17], we also applied OTR4120 to the con-
structed anastomosis to maximize the therapeutic eﬀect.
Therefore, we judge it as unlikely that the diﬀerences in
administration of OTR4120 would account for the lack of
eﬀect of OTR4120 on anastomotic breaking strength.
Another possibility is the time-dependent decline of the bio-
activity of OTR4120. Reapplication of OTR4120 to the anas-
tomosis in the early postoperative period is, however, not a
clinical option. However, anastomotic breaking strength
and bursting pressure are two measures that reﬂect diﬀerent
phenomena and are not signiﬁcantly correlated during early
anastomotic wound healing [31]. This ﬁnding could explain
the discrepancy with the study byMeddahi et al. [17] in anas-
tomotic wound healing.
In the early postoperative period, the suture-holding
submucosal collagen is responsible for the biomechanical
strength of colonic anastomoses. Collagen degradation
dominates over collagen biosynthesis during this period
[16]. OTR4120 did not inﬂuence the collagen levels of
the anastomoses.
The breaking strength of the incisional skin wounds on
postoperative day 3 is the force required to disrupt the
ﬁbrin-ﬁbronectin-rich but collagen-poor ganulation tissue
formed between the wound edges [12, 13]. The treatment
with OTR4120 did not enhance the biomechanical strength
of the incisional skin wounds. This ﬁnding contrasts with
the results from one previous study that reported beneﬁcial
eﬀects on cutaneous wound healing including increased
angiogenesis, granulation tissue formation, and epithelializa-
tion on postoperative days 3 and 7 in rats [25]. In addition,
OTR4120 signiﬁcantly improved the breaking strength of
the full-thickness excisional wounds (15mm in diameter
day 0) at later time points (days 14 and 79) than that tested
in our study [26]. In these studies, OTR4120 was also
administered systemically (1mg/kg weekly) in addition to
the single topical application of 8μg OTR4120 at the time
of wounding [25, 26]. Here, OTR4120 was not given
systemically to avoid the increased risk of adverse eﬀects.
The diﬀerence in the time between the initial injury and
application of OTR4120 could theoretically have an eﬀect
on the wound-healing outcome [25, 26]. This lag period
may be important because mimetic compounds are capable
of reducing the initial release of matrix-bound growth
factors, which may have a negative impact on wound healing
[19]. Regardless, the delay between the initial skin injury and
the application of OTR4120 was similar in the present study
and in the studies of Tong et al. [25, 26].
5. Conclusion
This experimental study failed to demonstrate any beneﬁcial
eﬀects of locally applied OTR4120 on the healing of colonic
anastomoses and incisional skin wounds on postoperative
day 3. No local or systemic adverse eﬀects of OTR4120 were
observed. However, the systemic administration of OTR4120
alone or in combination with topical OTR4120 application
should be examined in future studies.
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